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NON-SUSTAINED VENTRICULAN TACHYCARDIA ON HOLTER IS PzpT 
OF PROGNOSTIC SIGNIFICANCE IN ASYMPTOMATIC PATIENTS WITH 
HYPERIROPHIC CARDIONYOPATHY 
ELEVATED MYOCARDIAL 
CARDIOMYOPATHY: AN ARR 
HYPERTROPHIC 
m Stephen Epstein, Judith Winkler, 
Anthony Chang. NIA, Maryland 
mes D. Pickett, 
iovascular Disease of 
Non-sustained ventricular tachycardia (VT), recorded 
in >25% of patients with hypertrophic cardiomyopathy (HC) 
during 48-h&r Holter moni&ring, has been associated 
with a 3 to 4 fold increased incidence of sudden death 
(SD) : an 8% annual mortality that is unaffected by 
conventional antiarrhythmic (AA) therapy but eliminated 
entirely by amiodarone. These conclusions were however, 
based on studies that included patients with syncope as 
well as asymptomatic patients. In contrast, we have 
reported a high incidence of SD in 
whb receive amiodarone. 
HC patients with VT 
To assess the prognostic 
significance of VT on Holter, we studied the relation of 
“(’ I. -Cal, hemodynamic, and electrophysiologic (EP) 
variacies to iong term outcome in 207 HC patients using 
multivariate logistic analysis. VT on Holter was present 
in 105 (51X) patients. Of these, 32 were asymptomatic 
[17 received no therapy, 9 type la AA drugs (5 for atria1 
arrhythmias), and 6 Ca* or D blockers for angina]. 
Fourteen SD occurred during follow up period of 26 + 
To elucidate the clinical significance of increased 
myocardial norepinephrine and epinephrine concen- 
tration (MEC) in pts with 
investigated their 
ophic cardiomyopathy, we 
correlation with 48 hour ambulatory 
ECG arrhythmic parameters. The myocardial catecholamine 
concentrations 
(14% males, 
catechol-O-met 
Using ANOVA statistical analysis, a consistent difference 
could be shown 
[LG] 1,2,3) and 
grade 
4,s) (Fd=222.1, 
as (LG 
in pts with LG 
higher 
fresh 
tissue) than in fresh 
tissue). A simi ference was found for 
MEC (Fdm127.2, pc.0. ch was demonstrated to be 
markedly higher in pts with LG 5 (108 f 5.4 ng x g-1 
fresh tissue) than in LG I (80 f 5.7 ng x g-1 fresh 
tissue) arrhythmias. 
18 months (maximum, 7 years). Significant independent 
predictors of poor outcome were 1) inducibility of 
sustained VT at EP (R-3.1, p<O.OOOl). and 2) a history of 
cardiac arrest or syncope (O-2.9, p<O.OOl). Notably, VT 
on Holter did not significantly affect outcome and 
importantly, ppae of the asymptomatic patients with VT on 
Holter died suddenly or had syncope. 
VT on Holter does not identify HC patients 
who are at risk of SD, and 2) asymptomatic patients with 
VT on Holter have an excellent prognosis. Potent AA drugs 
e.g. amiodarone are unwarranted in this subgroup and may 
cause malignant arrhythmias to emerge resulting in SD. 
These results suggest that elevated myocardial 
catecholamines could be an important link in the genesis 
of s~ious arrhythmias in hypertrophic cardiomyopathy. 
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Several prior investigations have shown a circadian 
distribution in the occurrence of sudden death (SD) in 
patients with coronary artery disease. SD is also an 
important feature of the natural history of hypertrophic 
cardiomyopathy (NM). ConsequentTJ, this retrospective 
study was undertaken to determine whether SD in HCM 
occurred with a particular frequency throughout the day. 
Precise hour of SD could be ascertained in 84 patients 
with HCM evaluated by our institution; ages were 8-59 
years (mean 29) and 54 !65%) were male. SD did not 
occur uniformly throughout the day, but rather 
distributed in a bimodal pattern (p-0.01; 2-ha 
regression model); a disproportionate number of SD (36 of 
84, 43%) occurred in a peak, early in the day, 7 am to 1 
pm. A second peak occurrence of SD was evident in the 
early evening between 7 pm and 10 pm (18 of 84, 22%). In 
contrast, SD occurred infrequently during sleeping hours 
of the night and in mid-afternoon. This periodicity in 
the occurrence of SO was not influenced by cardioactive 
medications, age, gender, day of week, or month of year. 
However, patients who d 
exertion did so more co 
during moderate/severe 
nly during those peak morning 
i&al 
In conclusion, sudden death 
pattern of circadian 
variability over the 24-hour day, remarkably similar to 
that described in ischemie heart disease, with two peaks 
of occurrence, in the morning 7 am - 1 pm and in early 
evening 7 - 10 pm. These findings suggest that 
temporally related physiologic changes may play a role in 
sudden death in patients with HCM. 
LASER MYOPLASTY FOR HYPERTROPHIC CARDIOMYOPATHY: 
USE OF A THERMOCOUPLE TO CONTINUOUSLY MONITOR LASER- 
FIBER CONTACI’ WlTH MYOCARDIUM AND FOR DOS-Y. 
Dov Gal, John Hogan. Greg Brucker, 
Jeffrey M. Isner. St. Elizabeth’s Hospital, Tufts Uoiversirv 
School of Medicine, Boston, MA. - 
I 
We investigated the use of a catheter xnoualed 
thermocouple(TC) to monitor catheter(C) positioning and 
do&merry in the performance of Nd-YAG laser(L) myoplasty. 
Probe was mounted on a fixation wire .009” in diameter. 
Probe lempcrature(TP) is instantaneously transmitted to a 
monitor which displays an LED readout. In vitro studies 
demonstrated that Tp rose linearly with duration of 
exposure(EXP) and power when the L fiber(F) was in contact 
with the myocardium(M) and corresponded 10 incremental 
M necrosis. Tp in excess of IOCPC were associated with 
extensive charring of M and crater formation at the site of F 
c3nlac1. 
model. 
We then applied these findings in vivo in a canine 
A guiding C was advanced retrograde lo the left 
ventricle and positioned fluoroscopically with Ihe tip 
perpendicular to the M. The TC-fixation wire was implanted 
2-3 mm outside the guiding C, into the M. A 400~ F was then 
advanced and posliooed with its tip effacing the tip of the 
guiding C. L EXP was begun while Tp was continuously 
monitored via Lbe TC. If the Tg did not rise immediately upon 
beginning the EXP, rhe C was repositioned until an 
appropriate Tp rise occurred. When Tp approached lOO*C!, 
exposure was interrupted lo allow cooling lo occur. Using 
this method, a toral of 12 consecutive successful exposures 
were performed, all1 resulting in significant necrosis, 
ranging from 6x7xgmm to 6x25x30mm in size and without 
charring or crater formation. Conclusions: 1) C mounted TC 
can be used successfully in vivo to monitor laser 
interventions and 2) Tp changes at le laser-tissue interface 
CSQ be used to confirm F postitioniog and for on-line 
dosimerry. 
